Although almost a century has gone by since its first description in the country, Turkey has
not been able to eradicate brucellosis, which remains a major public health problem. In this …

The absence of specific diagnostic criteria, the urgency to begin plasma exchange
treatment, and the risk for complications from plasma exchange make the initial evaluation of …

The aim of the study is to review the clinical manifestations and the hematological findings of
brucellosis and pancytopenia, with or without hematological malignancies. The records of …

Brucellosis is a worldwide zoonotic disease associated with hemolytic complications,
including thrombotic microangiopathy (TMA) and hemolytic anemia. Autoimmune hemolytic …

BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) is a rare disease that is fatal if
it is not treated. Therapeutic plasma exchange (TPE) has resulted in excellent remission and …

Brucellosis is a major zoonosis with worldwide prevalence; more than half a million new
human cases are expected every year. The genus Brucella (B) encompasses 12 accepted …

Thrombotic thrombocytopenic purpura (TTP) is characterized by disseminated thrombotic
occlusions located in the microcirculation and a syndrome of microangiopathic hemolytic …

Background Thrombocytopenia is a frequent finding among ill returned travellers and may
be caused by a large number of different conditions, including infectious diseases specific or …

There is little information in the literature on the clinical progress of brucellosis in patients
affected by other non-infectious diseases; however, the infection can often trigger an …

Objective: To present a case of brucellosis-induced severe autoimmune hemolytic anemia
(AIHA) that was refractory to traditional corticosteroid treatment and eventually treated with …